Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ventavis To Cost $65,000 - $100,000 Per Year, CoTherix Says

Mar 22 2005

• By Andrew Shelton

Related Content

CoTherix Ventavis Clears FDA For Pulmonary Arterial Hypertension

Dec 30 2004

CoTherix Will Position Ventavis As Complement To Oral Pulmonary Arterial Hypertension Therapies

Dec 30 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window